news
Groundbreaking research demonstrates proof-of-concept for using CRISPR-Cas9 genome editing technology…
4 July 2018 | By Dr Zara Kassam (Drug Target Review)
Groundbreaking research demonstrates proof-of-concept for using CRISPR-Cas9 genome editing technology to correct the gene mutation responsible for AAT deficiency...